Immediate Impact

15 from Science/Nature 65 standout
Sub-graph 1 of 24

Citing Papers

Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study
2022 Standout
Endometrial cancer
2021 Standout

Works of John Andrews being referenced

Activity of durvalumab in advanced endometrial cancer (AEC) according to mismatch repair (MMR) status: The phase II PHAEDRA trial (ANZGOG1601).
2019

Author Peers

Author Last Decade Papers Cites
John Andrews 180 79 190 89 14 413
Egle Kvedaraite 146 39 377 52 12 512
Toshio Takada 38 58 48 135 16 392
Sanne Samuels 299 80 261 73 15 507
Charles P.T. Schijf 79 75 29 65 15 426
Aska Toda 83 45 115 36 19 451
Elissa McMurtrie 145 86 109 68 15 374
C Natter 89 113 69 87 14 412
M David 58 38 29 77 23 512
Mei‐Yung Yu 34 94 135 70 16 483
May M.Y. Yu 60 57 74 80 12 381

All Works

Loading papers...

Rankless by CCL
2026